ScreenerHero

PRFX PRF Technologies Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · painreform.com
0.8777USD-0.28%Mkt Cap: 3.07M $P/E: —

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intra…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap3.07M USD
Enterprise Value-8.21M USD
Revenue (TTM)31.00K USD
Gross Profit-53.00K USD
Net Income (TTM)-5.02M USD
Revenue/Share0.03 USD
Last Price0.8777 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.07
PEG—
EV/EBITDA1.94
EV/Revenue-264.70
P/S99.35
P/B0.17
EPS (TTM)-4.09
EPS (Forward)-12.06
52W Range
0.85190% of range7.950
52W High7.950 USD
52W Low0.8519 USD
Profitability
Gross Margin-311.76%
Oper. Margin-18114.28%
EBITDA Margin0.00%
Profit Margin-29541.18%
ROE-58.78%
ROA-41.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.96M USD
CapEx (TTM)2.00K USD
FCF Margin-7063.71%
FCF Yield-71.30%
Net Debt-11.48M USD
Net Debt/EBITDA2.71
Balance Sheet
Debt/Equity0.00
Current Ratio5.07
Quick Ratio5.00
Book Value/Sh5.22 USD
Cash/Share3.79 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateFeb 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.50M
Float2.87M
Insiders6.57%
Institutions6.69%
Short Interest
Short Ratio0.7d
Short % Float1.96%
Short % Out.1.96%
Shares Short68.53K
Short (prev mo.)200.67K
Technical
SMA 500.9921 (-11.5%)
SMA 2002.134 (-58.9%)
Beta1.08
S&P 52W Chg15.78%
Avg Vol (30d)274.35K
Avg Vol (10d)57.32K
Technical Indicators
RSI (14)39.4
MACD-0.0333
MACD Signal-0.0317
MACD Hist.-0.0016
BB Upper1.027 USD
BB Middle0.9350 USD
BB Lower0.8429 USD
BB Width19.70%
ATR (14)0.0731 USD
Vol Ratio (20d)0.04x